Status:
COMPLETED
HFCWO in Hospitalized Asthmatic Children
Lead Sponsor:
Hill-Rom
Conditions:
Bronchial Asthma
Asthma
Eligibility:
All Genders
18-18 years
Phase:
NA
Brief Summary
To determine whether or not high frequency chest wall oscillation (in the form of the VestTM) is superior to regular asthma therapy in the management of children hospitalized with moderate to severe a...
Detailed Description
A historically controlled pilot study was conducted in pediatric patients 18 months to 18 years of age hospitalized with a diagnosis of asthma or reactive airway disease and admitted to the pediatric ...
Eligibility Criteria
Inclusion
- Any pediatric patient between the ages of 18 months and 18 years admitted to Winthrop University Hospital's pediatric floor or intensive care unit with a diagnosis of asthma or reactive airway disease
Exclusion
- Patients with chronic, comorbid respiratory conditions (e.g., cerebral palsy, cystic fibrosis)
- Those who regularly use HFCWO
- Any patient exhibiting an absolute contraindication to HFCWO therapy
- Absolute contraindications to using HFCWO include head and neck injury prior to stabilization, and active hemorrhage with hemodynamic instability
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00722020
Start Date
July 1 2008
End Date
July 1 2010
Last Update
August 7 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Winthrop University Hospital, Winthrop Pediatric Associates
Long Island City, New York, United States, 11501
2
Winthrop University Hospital
Long Island City, New York, United States, 11501